|
00467 |
HADH Dificiency |
3-@HYDROXYACYL-CoA DEHYDROGENASE; HADH |
231530 |
0 |
0 |
, HADH |
|
00484 |
MEGDEL |
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL |
614739 |
0 |
0 |
SERAC1 |
|
00495 |
MGCA1 |
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1 |
250950 |
0 |
0 |
AUH |
|
00496 |
MGCA3 |
3-METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3 |
258501 |
0 |
0 |
OPA3 |
|
00079 |
MGCA5 |
3-METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5 |
610198 |
0 |
0 |
DNAJC19 |
|
00419 |
611126 |
ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9, DEFICIENCY OF |
611126 |
0 |
0 |
ACAD9 |
|
00434 |
ACADMD |
ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD |
201450 |
0 |
0 |
ACADM |
|
00435 |
ACADSD |
ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD |
201470 |
0 |
0 |
ACADS |
|
00436 |
ACADVLD |
ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD |
201475 |
0 |
0 |
ACADVL |
|
00147 |
502000 |
AGING aging represents a phenotype seemingly related to changes in mitochondrial DNA |
502000 |
0 |
0 |
- |
|
00081 |
610251 |
Alcohol sensitivity, acute, 610251 (3) |
610251 |
0 |
0 |
ALDH2 |
|
00402 |
203750 |
ALPHA-METHYLACETOACETIC ACIDURIA |
203750 |
0 |
0 |
ACAT1 |
|
00161 |
502500 |
ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL |
502500 |
0 |
0 |
- |
|
00083 |
SPAX4 |
Ataxia, spastic, 4, 613672 (3) |
613672 |
0 |
0 |
MTPAP |
|
00141 |
MTATP6 |
ATP SYNTHASE 6;;MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, MITOCHONDRIAL TYPE 1, INCLUDED |
516060 |
0 |
0 |
, MT-ATP6 |
|
00399 |
BTHS |
BARTH SYNDROME; BTHS |
302060 |
0 |
0 |
TAZ |
|
00084 |
BJS |
Bjornstad syndrome, 262000 (3) |
262000 |
0 |
0 |
BCS1L |
|
00085 |
237300 |
Carbamoylphosphate synthetase I deficiency;CPS I DEFICIENCY |
237300 |
0 |
0 |
CPS1 |
|
00482 |
CEMCOX1 |
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1 |
604377 |
0 |
0 |
SCO2 |
|
00086 |
CMD1GG |
Cardiomyopathy, dilated, 1GG, 613642 (3) |
613642 |
0 |
0 |
SDHA |
|
00151 |
500000 |
CARDIOMYOPATHY, INFANTILE HISTIOCYTOID |
500000 |
0 |
0 |
MT-CYB |
|
00438 |
212160 |
CARNITINE DEFICIENCY, MYOPATHIC |
212160 |
0 |
0 |
- |
|
00473 |
CDSP |
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP |
212140 |
0 |
0 |
SLC22A5 |
|
00440 |
255120 |
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY |
255120 |
0 |
0 |
-, CPT1A |
|
00466 |
CPT II |
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE;CPT2 |
600649 |
0 |
0 |
, CPT2 |
|
00486 |
255110 |
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET |
255110 |
0 |
0 |
CPT2 |
|
00487 |
608836 |
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL |
608836 |
0 |
0 |
CPT2 |
|
00437 |
CACTD |
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY;CACTD |
212138 |
0 |
0 |
SLC25A20 |
|
00444 |
CCDS3 |
CEREBRAL CREATINE DEFICIENCY SYNDROME 3; CCDS3 |
612718 |
0 |
0 |
GATM |
|
00488 |
CMT2A2 |
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2 |
609260 |
0 |
0 |
MFN2 |
|
00145 |
515000 |
CHLORAMPHENICOL TOXICITY;ANEMIA, CHLORAMPHENICOL-INDUCED;CHLORAMPHENICOL RESISTANCE, INCLUDED |
515000 |
0 |
0 |
, MT-RNR2 |
|
00088 |
CTLN2 |
Citrullinemia, adult-onset type II, 603471 (3) |
603471 |
0 |
0 |
SLC25A13 |
|
00089 |
605814 |
Citrullinemia, type II, neonatal-onset, 605814 (3) |
605814 |
0 |
0 |
SLC25A13 |
|
00090 |
COQ10D1 |
Coenzyme Q10 deficiency, primary, 1, 607426 (3) |
607426 |
0 |
0 |
COQ2 |
|
00446 |
COQ10D2 |
COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2 |
614651 |
0 |
0 |
PDSS1 |
|
00447 |
COQ10D3 |
COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3 |
614652 |
0 |
0 |
PDSS2 |
|
00443 |
COQ10D4 |
COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4 |
612016 |
0 |
0 |
ADCK3 |
|
00448 |
COQ10D5 |
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5 |
614654 |
0 |
0 |
COQ9 |
|
00480 |
COQ10D6 |
COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6 |
614650 |
0 |
0 |
COQ6 |
|
00091 |
D2L2AD |
Combined D-2- and L-2-hydroxyglutaric aciduria, 615182 (3) |
615182 |
0 |
0 |
SLC25A1 |
|
00092 |
COXPD1 |
Combined oxidative phosphorylation deficiency 1, 609060 (3) |
609060 |
0 |
0 |
GFM1 |
|
00093 |
COXPD10 |
Combined oxidative phosphorylation deficiency 10, 614702 (3) |
614702 |
0 |
0 |
MTO1 |
|
00423 |
COXPD11 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11 |
614922 |
0 |
0 |
RMND1 |
|
00094 |
COXPD14 |
Combined oxidative phosphorylation deficiency 14, 614946 (3) |
614946 |
0 |
0 |
FARS2 |
|
00095 |
COXPD15 |
Combined oxidative phosphorylation deficiency 15, 614947 (3) |
614947 |
0 |
0 |
MTFMT |
|
00080 |
COXPD16 |
Combined oxidative phosphorylation deficiency 16, 615395 (3) |
615395 |
0 |
0 |
MRPL44 |
|
00096 |
COXPD2 |
Combined oxidative phosphorylation deficiency 2, 610498 (3) |
610498 |
0 |
0 |
MRPS16 |
|
00097 |
COXPD3 |
Combined oxidative phosphorylation deficiency 3, 610505 (3) |
610505 |
0 |
0 |
TSFM |
|
00098 |
COXPD4 |
Combined oxidative phosphorylation deficiency 4, 610678 (3) |
610678 |
0 |
0 |
TUFM |
|
00099 |
COXPD5 |
Combined oxidative phosphorylation deficiency 5, 611719 (3) |
611719 |
0 |
0 |
MRPS22 |
|
00411 |
COXPD6 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6 |
300816 |
0 |
0 |
AIFM1 |
|
00493 |
COXPD7 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7 |
613559 |
0 |
0 |
C12orf65 |
|
00076 |
COXPD8 |
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8 |
614096 |
0 |
0 |
AARS2 |
|
00100 |
COXPD9 |
Combined oxidative phosphorylation deficiency 9, 614582 (3) |
614582 |
0 |
0 |
MRPL3 |
|
00150 |
CVS |
CYCLIC VOMITING SYNDROME; CVS |
500007 |
0 |
0 |
MT-TL1 |
|
00465 |
MTCYB |
CYTOCHROME b OF COMPLEX III; MTCYB |
516020 |
0 |
0 |
, MT-CYB |
|
00101 |
613657 |
D-2-hydroxyglutaric aciduria 2, 613657 (3) |
613657 |
0 |
0 |
IDH2 |
|
00051 |
580000 |
DEAFNESS, AMINOGLYCOSIDE-INDUCED;STREPTOMYCIN-INDUCED |
580000 |
0 |
0 |
-, MT-CO1, MT-RNR1, TRMU |
|
00489 |
DFNB1A |
DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1A |
220290 |
0 |
0 |
GJB2, GJB3, GJB6 |
|
00159 |
500008 |
DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL |
500008 |
0 |
0 |
-, MT-ND1, MT-RNR1, MT-TH, MT-TI, MT-TS1 |
|
00404 |
221745 |
DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE |
221745 |
0 |
0 |
- |
|
00165 |
MIDD |
DIABETES AND DEAFNESS, MATERNALLY INHERITED;MIDD |
520000 |
0 |
0 |
MT-TE, MT-TK, MT-TL1 |
|
00102 |
NIDDM |
Diabetes mellitus, noninsulin-dependent, 125853 (3) |
125853 |
0 |
0 |
ABCC8, AKT2, CAPN10, CDKAL1, ENPP1, GCGR, GCK, GPD2, HMGA1, HNF1B, HNF4A, IGF2BP2, IL6, INSR, IRS1, KCNJ11, LIPC, MAPK8IP1, NEUROD1, PAX4, 7 more |
|
00164 |
520100 |
DIARRHEA, CHRONIC, WITH VILLOUS ATROPHY Links |
520100 |
0 |
0 |
- |
|
00401 |
614520 |
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY |
614520 |
0 |
0 |
- |
|
00014 |
614388 |
Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission, 614388 (3) |
614388 |
0 |
0 |
DNM1L |
|
00103 |
EIEE3 |
Epileptic encephalopathy, early infantile, 3, 609304 (3) |
609304 |
0 |
0 |
SLC25A22 |
|
00491 |
FRDA;FRDA1;FA |
FRIEDREICH ATAXIA 1; FRDA;FRIEDREICH ATAXIA WITH RETAINED REFLEXES, INCLUDED; FARR, INCLUDED |
229300 |
0 |
0 |
FXN |
|
00104 |
603358 |
GRACILE syndrome, 603358 (3) |
603358 |
0 |
0 |
BCS1L |
|
00105 |
605911 |
HMG-CoA synthase-2 deficiency, 605911 (3);MITOCHONDRIAL HMG-CoA SYNTHASE DEFICIENCY |
605911 |
0 |
0 |
HMGCS2 |
|
00405 |
238710 |
HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA |
238710 |
0 |
0 |
- |
|
00406 |
LUFT |
HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA;LUFT DISEASE |
238800 |
0 |
0 |
- |
|
00106 |
238970 |
Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3) |
238970 |
0 |
0 |
SLC25A15 |
|
00148 |
500005 |
HYPOMAGNESEMIA, HYPERTENSION, AND HYPERCHOLESTEROLEMIA, MITOCHONDRIAL, caused by a mutation in the mitochondrial tRNA(Ile) gene (590045). MT-TI |
500005 |
0 |
0 |
MT-TI |
|
00107 |
612949 |
Hypomyelination, global cerebral, 612949 (3) |
612949 |
0 |
0 |
SLC25A12 |
|
00416 |
606407 |
HYPOTONIA-CYSTINURIA SYNDROME |
606407 |
0 |
0 |
- |
|
00108 |
ICRD |
Infantile cerebellar-retinal degeneration, 614559 (3)??mitochondrial? |
614559 |
0 |
0 |
ACO2 |
|
00143 |
KSS |
KEARNS-SAYRE SYNDROME, caused by various mitochondrial deletions |
530000 |
0 |
0 |
MT-TL1 |
|
00149 |
LDYT |
LEBER OPTIC ATROPHY AND DYSTONIA, alt: LEBER HEREDITARY OPTIC NEUROPATHY WITH DYSTONIA; LDYT;; DYSTONIA, FAMILIAL, WITH VISUAL FAILURE AND STRIATAL LUCENCIES;; MARSDEN SYNDROME |
500001 |
0 |
0 |
MT-ND1, MT-ND3, MT-ND4, MT-ND6 |
|
00072 |
LHON |
LEBER OPTIC ATROPHY, LEBER HEREDITARY OPTIC NEUROPATHY; DOID:705 |
535000 |
0 |
0 |
-, MT-ATP6, MT-CO3, MT-CYB, MT-ND1, MT-ND2, MT-ND4, MT-ND4L, MT-ND5, MT-ND6 |
|
00492 |
LOAS |
LEBER OPTIC ATROPHY, SUSCEPTIBILITY TO;LHON, MODIFIER OF;LOAS |
308905 |
0 |
0 |
- |
|
00015 |
LS |
Leigh syndrome due to mitochondrial complex 1 deficiency, 256000 (3) |
256000 |
1 |
0 |
BCS1L, COX10, COX15, FOXRED1, MT-ATP6, MT-TK, MT-TV, MT-TW, NDUFA10, NDUFA12, NDUFA2, NDUFA9, NDUFAF2, NDUFAF6, NDUFS3, NDUFS4, NDUFS7, NDUFS8, SDHA, SURF1 |
|
00389 |
LSFC |
Leigh syndrome, French-Canadian type, 220111 (3) |
220111 |
0 |
0 |
LRPPRC |
|
00390 |
308930 |
Leigh syndrome, X-linked, 308930 (3) |
308930 |
0 |
0 |
PDHA1 |
|
00421 |
HLD4 |
LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4 |
612233 |
0 |
0 |
HSPD1 |
|
00418 |
611105 |
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND |
611105 |
0 |
0 |
DARS2 |
|
00494 |
MSL |
LIPOMATOSIS, MULTIPLE SYMMETRIC; MSL |
151800 |
0 |
0 |
MFN2 |
|
00110 |
LFIT |
Liver failure, transient infantile, 613070 (3) |
613070 |
0 |
0 |
TRMU, TRNT1 |
|
00474 |
LCHAD |
LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY |
609016 |
0 |
0 |
, HADHA |
|
00112 |
MCPHA |
Microcephaly, Amish type, 607196 (3) |
607196 |
0 |
0 |
SLC25A19 |
|
00010 |
615228 |
Mitochondrial complex (ATP synthase) deficiency, nuclear type 4, 615228 (3) |
615228 |
0 |
0 |
ATP5A1 |
|
00011 |
252010 |
Mitochondrial complex I deficiency, 252010 (3) |
252010 |
0 |
0 |
FOXRED1, MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-TN, NDUFA1, NDUFA11, NDUFAF1, NDUFAF2, NDUFAF3, NDUFAF4, NDUFAF5, NDUFB3, NDUFB9, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS6, 4 more |
|
00016 |
252011 |
Mitochondrial complex II deficiency, 252011 (3) |
252011 |
0 |
0 |
SDHA, SDHAF1 |
|
00017 |
MC3DN1 |
Mitochondrial complex III deficiency, nuclear type 1, 124000 (3) |
124000 |
0 |
0 |
BCS1L, UQCRB |
|
00018 |
MC3DN2 |
Mitochondrial complex III deficiency, nuclear type 2, 615157 (3) |
615157 |
0 |
0 |
TTC19 |
|
00019 |
MC3DN3 |
Mitochondrial complex III deficiency, nuclear type 3, 615158 (3) |
615158 |
0 |
0 |
, UQCRB |
|
00020 |
MC3DN4 |
Mitochondrial complex III deficiency, nuclear type 4, 615159 (3) |
615159 |
0 |
0 |
UQCRQ |
|
00021 |
MC3DN5 |
Mitochondrial complex III deficiency, nuclear type 5, 615160 (3) |
615160 |
0 |
0 |
UQCRC2 |
|
00022 |
MC3DN6 |
Mitochondrial complex III deficiency, nuclear type 6, 615453 (3) |
615453 |
0 |
0 |
CYC1 |
|
00012 |
220110 |
Mitochondrial complex IV deficiency, 220110 (3) |
220110 |
2 |
0 |
APOPT1, COA5, COX10, COX14, COX20, COX6B1, FASTKD2, MT-CO1, MT-CO2, MT-CO3, MT-TL1, MT-TN, SCO1, SURF1, TACO1 |
|
00023 |
604273 |
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1, 604273 (3) |
604273 |
0 |
0 |
ATPAF2 |
|
00024 |
614052 |
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2, 614052 (3) |
614052 |
0 |
0 |
TMEM70 |
|
00025 |
614053 |
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, 614053 (3) |
614053 |
0 |
0 |
ATP5E |
|
00026 |
MTDPS1 |
Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3) |
603041 |
0 |
0 |
MT-TK, POLG, TYMP |
|
00027 |
MTDPS11 |
Mitochondrial DNA depletion syndrome 11, 615084 (3) |
615084 |
0 |
0 |
MGME1 |
|
00028 |
MTDPS12 |
Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type), 615418 (3) |
615418 |
0 |
0 |
SLC25A4 |
|
00029 |
MTDPS13 |
Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type);MTDPS13 |
615471 |
0 |
0 |
FBXL4 |
|
00030 |
MTDPS2 |
Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3) |
609560 |
0 |
0 |
TK2 |
|
00031 |
MTDPS3 |
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), 251880 (3) |
251880 |
0 |
0 |
C10orf2, DGUOK |
|
00032 |
MTDPS4A |
Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 |
203700 |
0 |
0 |
POLG |
|
00033 |
MTDPS4B |
Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3) |
613662 |
0 |
0 |
POLG |
|
00034 |
612073 |
Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria), 612073 (3) |
612073 |
0 |
0 |
SUCLA2 |
|
00035 |
MTDPS6 |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810 (3) |
256810 |
0 |
0 |
MPV17 |
|
00036 |
MTDPS7 |
Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3) |
271245 |
0 |
0 |
C10orf2 |
|
00037 |
612075 |
Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3) |
612075 |
0 |
0 |
RRM2B |
|
00038 |
245400 |
Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), 245400 (3) |
245400 |
0 |
0 |
SUCLG1 |
|
00039 |
MLASA1 |
Mitochondrial myopathy and sideroblastic anemia 1, 600462 (3) |
600462 |
0 |
0 |
, PUS1 |
|
00407 |
251945 |
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT |
251945 |
0 |
0 |
- |
|
00146 |
500002 |
MITOCHONDRIAL MYOPATHY WITH DIABETES |
500002 |
0 |
0 |
, MT-TE |
|
00408 |
251950 |
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS |
251950 |
0 |
0 |
- |
|
00163 |
MELAS SYNDROME |
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES;DOID:3687 |
540000 |
1 |
2 |
MT-ND1, MT-ND4, MT-ND5, MT-ND6, MT-TC, MT-TF, MT-TH, MT-TK, MT-TL1, MT-TQ, MT-TS1, MT-TS2 |
|
00158 |
MMIT |
MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT;MMIT |
500009 |
0 |
0 |
MT-TE |
|
00172 |
LIMM |
MITOCHONDRIAL MYOPATHY, LETHAL, INFANTILE |
551000 |
0 |
0 |
- |
|
00400 |
CPEO,CPEO Plus |
MITOCHONDRIAL MYOPATHY: CPEO, CPEO "Plus" DOID:12558, Chronic progressive external ophthalmoplegia |
251900 |
0 |
0 |
MT-TA, MT-TL2, MT-TM, MT-TW |
|
00040 |
610773 |
Mitochondrial phosphate carrier deficiency, 610773 (3) |
610773 |
0 |
0 |
SLC25A3 |
|
00041 |
MPYCD |
Mitochondrial pyruvate carrier deficiency, 614741 (3) |
614741 |
0 |
0 |
MPC1 |
|
00042 |
SANDO |
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3) |
607459 |
0 |
0 |
C10orf2, POLG |
|
00113 |
MTS |
Mohr-Tranebjaerg syndrome, 304700 (3) |
304700 |
0 |
0 |
TIMM8A |
|
00464 |
201460 |
MOVED TO 201475 |
201460 |
0 |
0 |
ACADVL |
|
00439 |
MADD |
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD |
231680 |
0 |
0 |
, ETFA, ETFB, ETFDH |
|
00043 |
MMDS1 |
Multiple mitochondrial dysfunctions syndrome 1, 605711 (3) |
605711 |
0 |
0 |
NFU1 |
|
00044 |
MMDS2 |
Multiple mitochondrial dysfunctions syndrome 2, 614299 (3) |
614299 |
0 |
0 |
BOLA3 |
|
00013 |
MMDS3 |
Multiple mitochondrial dysfunctions syndrome 3, 615330 (3) |
615330 |
0 |
0 |
IBA57 |
|
00415 |
MDCMC |
MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC |
602541 |
0 |
0 |
CHKB |
|
00162 |
MERRF |
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS; MERRF SYNDROME |
545000 |
1 |
0 |
MT-ND5, MT-TF, MT-TH, MT-TK, MT-TL1, MT-TS1, MT-TS2 |
|
00166 |
550500 |
MYOGLOBINURIA, RECURRENT |
550500 |
0 |
0 |
MT-CO1 |
|
00409 |
255140 |
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA |
255140 |
0 |
0 |
- |
|
00476 |
HML |
MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY; HML |
255125 |
0 |
0 |
ISCU |
|
00472 |
MLASA2 |
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2 |
613561 |
0 |
0 |
YARS2 |
|
00045 |
613076 |
Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay, 613076 (3) |
613076 |
0 |
0 |
GFER |
|
00433 |
161700 |
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT |
161700 |
0 |
0 |
- |
|
00171 |
551200 |
NEPHROPATHY, CHRONIC TUBULOINTERSTITIAL |
551200 |
0 |
0 |
- |
|
00422 |
NBIA4 |
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4 |
614298 |
0 |
0 |
C19orf12 |
|
00392 |
NF2 |
Neurofibromatosis, type 2, 101000 (3) |
101000 |
0 |
0 |
NF2 |
|
00168 |
NARP SYNDROME |
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA;NARP SYNDROME |
551500 |
0 |
0 |
MT-ATP6 |
|
00485 |
HSMN6 |
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VI; HSMN6 |
601152 |
0 |
0 |
MFN2 |
|
00114 |
601665 |
Obesity, autosomal dominant, 601665 (3) |
601665 |
0 |
0 |
-, ADRB2, ADRB3, CARTPT, ENPP1, GHRL, KANK1, LEPR, MC4R, more than 10, MRAP2, MT-CYB, PYY, UCP1, UCP3 |
|
00167 |
553000 |
ONCOCYTOMA |
553000 |
0 |
0 |
, MT-ND6 |
|
00410 |
258470 |
OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA |
258470 |
0 |
0 |
- |
|
00073 |
OPA1 |
OPTIC ATROPHY 1; OPA1 |
165500 |
0 |
0 |
OPA1 |
|
00170 |
556500 |
PARKINSON DISEASE, MITOCHONDRIAL |
556500 |
0 |
0 |
MT-TK, NDUFV2 |
|
00169 |
557000 |
PEARSON MARROW-PANCREAS SYNDROME |
557000 |
0 |
0 |
- |
|
00046 |
261650 |
PEPCK deficiency, mitochondrial, 261650 (1) |
261650 |
0 |
0 |
, PCK2 |
|
00483 |
PRLTS2 |
PERRAULT SYNDROME 2; PRLTS2 |
614926 |
0 |
0 |
HARS2 |
|
00116 |
PRLTS4 |
Perrault syndrome 4, 615300 (3) |
615300 |
0 |
0 |
LARS2 |
|
00420 |
PCH6 |
PONTOCEREBELLAR HYPOPLASIA, TYPE 6; PCH6 |
611523 |
0 |
0 |
RARS2 |
|
00047 |
609283 |
Progressive external ophthalmoplegia with mitochondrial DNA deletions 3, 609283 (3) |
609283 |
0 |
0 |
SLC25A4 |
|
00048 |
610131 |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4, 610131 (3) |
610131 |
0 |
0 |
POLG2 |
|
00074 |
PEOA3 |
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 3; PEOA3 |
609286 |
0 |
0 |
C10orf2 |
|
00049 |
PEOA5 |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5, PEOA5 |
613077 |
0 |
0 |
RRM2B |
|
00050 |
PEOA6 |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 6, PEOA6 |
615156 |
0 |
0 |
DNA2 |
|
00117 |
PEOA1 |
Progressive external ophthalmoplegia, autosomal dominant, 157640 (3) |
157640 |
0 |
0 |
POLG |
|
00118 |
258450 |
Progressive external ophthalmoplegia, autosomal recessive, 258450 (3) |
258450 |
0 |
0 |
POLG |
|
00412 |
600706 |
PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA |
600706 |
0 |
0 |
- |
|
00398 |
266150 |
Pyruvate carboxylase deficiency, 266150 (3) |
266150 |
0 |
0 |
PC |
|
00442 |
PDHAD |
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD |
312170 |
0 |
0 |
, PDHA1 |
|
00478 |
PDHBD |
PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD |
614111 |
0 |
0 |
PDHB |
|
00475 |
PDHDD |
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD |
245348 |
0 |
0 |
DLAT |
|
00479 |
PDHLD |
PYRUVATE DEHYDROGENASE LIPOIC ACID SYNTHETASE DEFICIENCY; PDHLD |
614462 |
0 |
0 |
LIAS |
|
00477 |
PDHPD |
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY; PDHPD |
608782 |
0 |
0 |
PDP1 |
|
00144 |
560000 |
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA, caused by duplication of mitochondrial DNA |
560000 |
0 |
0 |
- |
|
00119 |
267500 |
Reticular dysgenesis, 267500 (3) |
267500 |
0 |
0 |
AK2 |
|
00160 |
500004 |
RETINITIS PIGMENTOSA-DEAFNESS SYNDROME |
500004 |
0 |
0 |
CDH23, CLRN1, DFNB31, GPR98, MT-TS2, MYO7A, PCDH15, USH1C, USH1G, USH2A |
|
00403 |
212350 |
SENGERS SYNDROME |
212350 |
0 |
0 |
AGK |
|
00497 |
SPG7 |
SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7 |
607259 |
0 |
0 |
- |
|
00498 |
SCA28 |
SPINOCEREBELLAR ATAXIA 28; SCA28 |
610246 |
0 |
0 |
AFG3L2 |
|
00157 |
500003 |
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL |
500003 |
0 |
0 |
MT-ATP6 |
|
00075 |
SNDI |
STRIATONIGRAL DEGENERATION, INFANTILE; SNDI |
271930 |
0 |
0 |
NUP62 |
|
00417 |
609015 |
TRIFUNCTIONAL PROTEIN DEFICIENCY |
609015 |
0 |
0 |
HADHA, HADHB |
|
00490 |
WFS2 |
WOLFRAM SYNDROME 2; WFS2 |
604928 |
0 |
0 |
CISD2 |
|
00156 |
598500 |
WOLFRAM SYNDROME, MITOCHONDRIAL FORM |
598500 |
0 |
0 |
- |
|
00125 |
PHN |
{Pulmonary hypertension, neonatal, susceptibility to}, 615371 (3) |
615371 |
0 |
0 |
CPS1 |